| Literature DB >> 25820063 |
Yoshimi Tsuda1, Christopher J Parkins2, Patrizia Caposio2, Friederike Feldmann3, Sara Botto2, Susan Ball4, Ilhem Messaoudi5, Luka Cicin-Sain6, Heinz Feldmann1, Michael A Jarvis7.
Abstract
Ebola virus (Zaire ebolavirus; EBOV) is a highly lethal hemorrhagic disease virus that most recently was responsible for two independent 2014 outbreaks in multiple countries in Western Africa, and the Democratic Republic of the Congo, respectively. Herein, we show that a cytomegalovirus (CMV)-based vaccine provides durable protective immunity from Ebola virus following a single vaccine dose. This study has implications for human vaccination against ebolaviruses, as well as for development of a 'disseminating' vaccine to target these viruses in wild African great apes.Entities:
Keywords: Cytomegalovirus; Disseminating; Durable; Ebola; Ebolavirus; Great apes; Mouse; Protection; Vaccine
Mesh:
Substances:
Year: 2015 PMID: 25820063 PMCID: PMC4402448 DOI: 10.1016/j.vaccine.2015.03.029
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641